- Home
- STEW vs HROW Comparison
STEW vs HROW Comparison
Compare STEW & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEW
- HROW
- Stock Information
- Founded
- STEW 1972
- HROW 1998
- Country
- STEW United States
- HROW United States
- Employees
- STEW N/A
- HROW N/A
- Industry
- STEW Investment Managers
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- STEW Finance
- HROW Health Care
- Exchange
- STEW Nasdaq
- HROW Nasdaq
- Market Cap
- STEW 1.8B
- HROW 1.4B
- IPO Year
- STEW N/A
- HROW N/A
- Fundamental
- Price
- STEW $17.70
- HROW $38.24
- Analyst Decision
- STEW
- HROW Strong Buy
- Analyst Count
- STEW 0
- HROW 7
- Target Price
- STEW N/A
- HROW $68.50
- AVG Volume (30 Days)
- STEW 84.5K
- HROW 856.1K
- Earning Date
- STEW 01-01-0001
- HROW 11-12-2025
- Dividend Yield
- STEW 3.71%
- HROW N/A
- EPS Growth
- STEW N/A
- HROW N/A
- EPS
- STEW 1.44
- HROW N/A
- Revenue
- STEW N/A
- HROW $227,661,000.00
- Revenue This Year
- STEW N/A
- HROW $43.92
- Revenue Next Year
- STEW N/A
- HROW $41.32
- P/E Ratio
- STEW $10.34
- HROW N/A
- Revenue Growth
- STEW N/A
- HROW 47.69
- 52 Week Low
- STEW $11.97
- HROW $20.85
- 52 Week High
- STEW $14.94
- HROW $55.75
- Technical
- Relative Strength Index (RSI)
- STEW 44.59
- HROW 43.90
- Support Level
- STEW $17.66
- HROW $37.69
- Resistance Level
- STEW $17.93
- HROW $39.77
- Average True Range (ATR)
- STEW 0.18
- HROW 2.31
- MACD
- STEW -0.01
- HROW -0.32
- Stochastic Oscillator
- STEW 42.98
- HROW 38.79
About STEW SRH Total Return Fund Inc.
SRH Total Return Fund, Inc. is a non-diversified closed-end management investment company. The company's investment objective is to seek total returns. Its fund utilizes a bottom-up, value-driven investment process to identify securities of good quality businesses trading below estimated intrinsic value. The Funds are available as an actively-managed closed-end fund, an actively managed ETF and a passively-managed ETF.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.